Filter
13832
Filtered Results: 13832
Text search:
health
risks
Featured
Recommendations
1161
New Publications
3242
Language
Document type
No document type
7181
Studies & Reports
2442
Guidelines
1750
Manuals
690
Fact sheets
550
Strategic & Response Plan
456
Training Material
254
Situation Updates
173
Infographics
112
Resource Platforms
90
Brochures
53
Online Courses
39
Videos
28
Dashboards/Maps
13
App
1
Countries / Regions
Global
703
India
562
Kenya
343
South Africa
270
Sierra Leone
266
Ethiopia
250
Nigeria
244
Western and Central Europe
237
Liberia
230
Nepal
225
Uganda
221
Latin America and the Carribbean
214
Myanmar / Burma
200
Africa
189
Syria
175
Tanzania
170
Bangladesh
168
Rwanda
164
Zambia
163
Malawi
156
Ukraine
148
Congo, Democratic Republic of
138
Indonesia
128
Ghana
127
Namibia
113
Philippines
111
Russia
109
Brazil
105
South Sudan
104
Eastern Europe
94
Mozambique
93
Zimbabwe
91
South–East Asia Region
87
Senegal
83
West and Central Africa
83
Yemen
82
Middle East and North Africa
81
Guinea
80
Germany
79
Haiti
77
Lesotho
74
Cambodia
73
Venezuela
71
East and Southern Africa
71
Asia
70
Burkina Faso
59
Colombia
52
Eastern Europe and Central Asia
50
Botswana
50
Afghanistan
44
Pakistan
40
Cameroon
38
Lebanon
38
Central African Republic
36
Sudan
35
Mali
34
Eswatini/ Swaziland
34
Somalia
31
Madagascar
29
Benin
27
Jordan
27
Thailand
26
Western Pacific Region
26
Paraguay
26
Peru
24
USA
24
Vietnam
24
Angola
23
Tajikistan
22
China
22
Côte d’Ivoire / Ivory Coast
22
Iraq
21
North America
20
Niger
18
Chile
17
Guinea-Bissau
17
Argentina
17
Turkey
16
Moldova
16
Sri Lanka
16
Ecuador
15
Albania
14
Laos
14
Palestine
14
Chad
14
Spain
13
Georgia
12
Togo
11
Burundi
11
Egypt
11
Libya
11
Mexico
10
Iran
10
United Kingdom
10
Bolivia
10
North Macedonia
9
Saudi Arabia
9
Greece
9
El Salvador
8
Kazakhstan
8
Kyrgyzstan
8
Papua New Guinea
8
Armenia
7
Jamaica
7
Belarus
7
Timor Leste/ East Timor
6
Gambia
6
Malaysia
6
Italy
6
Tunisia
6
Portugal
6
Southern Africa
6
Romania
6
Poland
6
Honduras
6
Guatemala
6
Serbia
5
Singapore
5
Estonia
5
Hungary
5
Ireland
5
Turkmenistan
5
Canada
4
Uzbekistan
4
Morocco
4
Dominican Republic
4
Japan
4
Nicaragua
4
Djibouti
4
Bhutan
4
Switzerland
3
Australia
3
Fiji
3
Vanuatu
3
Mongolia
3
Qatar
3
Mauritania
3
Croatia
3
France
3
Mauritius
3
Israel
3
Bosnia and Herzegovina
3
North Korea
2
Congo-Brazzaville
2
Bulgaria
2
Lithuania
2
Belgium
2
Azerbaijan
2
Guyana
2
Austria
1
Cape Verde
1
Gabon
1
Uruguay
1
Denmark
1
Maldives
1
Norway
1
South Korea
1
Algeria
1
Morocco
1
French Guyana
1
Latvia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Slovakia
1
Solomon Islands
1
Bahamas
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
4880
Clinical Guidelines
900
Key Resources
758
Public Health
752
Women & Child Health
664
Capacity Building
304
Pharmacy & Technologies
111
Annual Report MEDBOX
3
Toolboxes
COVID-19
1621
Mental Health
1096
HIV
967
TB
655
Planetary Health
537
Ebola & Marburg
480
NCDs
449
Disability
431
NTDs
396
Rapid Response
387
Conflict
382
Caregiver
343
AMR
343
Refugee
301
Global Health Education
231
Natural Hazards
198
Pharmacy
182
Health Financing Toolbox
163
Malaria
158
Zika
134
Cholera
104
Specific Hazards
84
Polio
75
Social Ethics
39
2.0 Rapid Response
20
Typhoon
12
South Sudan
2
Interim Guidance.
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including semen. Ebola survivors need comprehensive support for the medical and psychosocial challenges they face and also to minimize the ...
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including semen. Ebola survivors need comprehensive support for the medical and psychosocial challenges they face and also to minimize the ...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
1PEP GUIDELINES | 2019 EDITION. The prevalence of both HIV and Hepatitis B is high in South Africa therefore there is a significant risk of acquiring these infections following exposure to infected material. Studies suggest that post- exposure prophylaxis (PEP) with highly active antiretroviral trea...
- The goal of diagnostic testing for Ebola and Marburg virus diseases is to identify cases to provide timely and appropriate care and to stop disease transmission.
- All individuals meeting the case definition for Ebola or Marburg virus diseases should be tested.
- The recommended sample type ...
Adolescent girls and young women (AGYW) remain disproportionately affected by HIV in Eastern and Southern Africa (ESA), with 26 per cent of new infections attributed to this population. AGYW face many personal, social and structural barriers to access, uptake and use of traditional HIV prevention me...
The manual provides suggestions for implementing the checklist, understanding that different practice settings will adapt it to their own circumstances.
The implementation manual is designed to help ensure that surgical teams are able to implement the checklist consistently. By following a few cri...
The aims of these guidelines are to provide guidance to health-care providers (i.e. the end-users of these guidelines: physicians, nurses, pharmacists and caregivers) on the adequate relief of pain associated with cancer. They also assist policy-makers, programme managers and public health personnel...
WHO TRS N°1012.
Key updates include: (i) surveillance strategies, including cross-sectoral linking of systems and suitable diagnostics; (ii) the latest recommendations on human and animal immunization; (iii) palliative care in lowresource settings; (iv) risk assessment to guide management of bite...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
The WHO health advisory provides guidance to countries on adapting all existing preparedness and response plans and procedures for natural hazards such as cyclones, tropical storms, tornadoes, floods, earthquakes and potential outbreaks of other diseases to their existing COVID-19 strategic prepared...
Evidence-based guidelines are one of the most useful tools for improving public health and clinical practice. Their purpose is to formulate interventions based on strong evidence of efficacy, avoid unnecessary risks, use resources efficiently, reduce clinical variability and, in essence, improve hea...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...
The technical note by the Global Task Force on Cholera Control (GTFCC) discusses the use of Oral Cholera Vaccines (OCVs) for international workers and travelers in cholera-affected areas. It reviews the effectiveness of WHO-prequalified vaccines (Dukoral®, Shanchol™, and Euvichol®), emphasizing ...
This document is a situation report (#6) from October 2, 2017, describing the cholera outbreak in Yemen. By October 1, 2017, there were 777,229 suspected cholera cases and 2,134 deaths across 22 of Yemen's 23 governorates. The response involves WASH partners providing hygiene supplies and water trea...
The main objective of this mission was to assess the level of preparedness of Guinea-Bissau in respect of the WHO consolidated checklist. The checklist helps countries to assess and test their level of readiness it is being used to identify concrete action to be taken and where countries will requir...
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited information on the prevalence of BU–HIV coinfection....
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,...
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In this edition, new information includes updated mask re...
Onchocerciasis used to be an important public health problem in Africa, with over 37 million people infected and millions suffering from debilitating skin disease, terrible itching, impaired vision and
blindness. But the epidemiological situation has improved dramatically over the last two decades....
